Compounds > dapivirine
Page last updated: 2024-09-05

dapivirine and levonorgestrel

dapivirine has been researched along with levonorgestrel in 4 studies

Compound Research Comparison

Studies
(dapivirine)		Trials
(dapivirine)		Recent Studies (post-2010)
(dapivirine)		Studies
(levonorgestrel)		Trials
(levonorgestrel)		Recent Studies (post-2010) (levonorgestrel)
196641604,8181,0041,763

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Brimer, A; Devlin, B; Major, I; McConville, C1
Blanda, W; Boyd, P; Brimer, A; Devlin, B; Fetherston, SM; Holt, J; Kumar, S; Major, I; Malcolm, RK; McCoy, CF; Murphy, DJ1
Boyd, P; Dallal Bashi, YH; Devlin, B; Kleinbeck, K; Malcolm, RK; McCoy, CF; Murphy, DJ; Spence, P1
Avenant, C; Dlamini, S; Enfield, K; Hapgood, JP; Kuipa, M1

Other Studies

4 other study(ies) available for dapivirine and levonorgestrel

ArticleYear
Development of a multi-layered vaginal tablet containing dapivirine, levonorgestrel and acyclovir for use as a multipurpose prevention technology.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2016, Volume: 104

    Topics: Acyclovir; Contraceptive Devices, Female; Female; HIV Infections; Humans; Levonorgestrel; Pyrimidines; Tablets; Vagina

2016
Matrix and reservoir-type multipurpose vaginal rings for controlled release of dapivirine and levonorgestrel.
    International journal of pharmaceutics, 2016, Sep-10, Volume: 511, Issue:1

    Topics: Contraceptive Agents, Female; Contraceptive Devices, Female; Delayed-Action Preparations; Drug Liberation; HIV Reverse Transcriptase; HIV-1; Levonorgestrel; Pyrimidines

2016
Towards a dapivirine and levonorgestrel multipurpose vaginal ring: Investigations into the reaction between levonorgestrel and addition-cure silicone elastomers.
    International journal of pharmaceutics, 2019, Oct-05, Volume: 569

    Topics: Anti-HIV Agents; Contraceptive Agents, Female; Contraceptive Devices, Female; Levonorgestrel; Pyrimidines; Silicone Elastomers

2019
Maraviroc, tenofovir disoproxil fumarate and dapivirine, activate progesterone receptor B in the absence of progestogens.
    Biochemical and biophysical research communications, 2020, 12-17, Volume: 533, Issue:4

    Topics: Anti-HIV Agents; Binding, Competitive; Cell Line; Contraceptive Agents, Hormonal; HIV Infections; HIV-1; Humans; Immunologic Factors; In Vitro Techniques; Levonorgestrel; Maraviroc; Phosphorylation; Progesterone Congeners; Pyrimidines; Receptors, Progesterone; Tenofovir; Transcriptional Activation

2020